These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25187371)

  • 1. PRMT3 regulates hepatic lipogenesis through direct interaction with LXRα.
    Kim DI; Park MJ; Lim SK; Park JI; Yoon KC; Han HJ; Gustafsson JÅ; Lim JH; Park SH
    Diabetes; 2015 Jan; 64(1):60-71. PubMed ID: 25187371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thioredoxin-interacting protein mediates hepatic lipogenesis and inflammation via PRMT1 and PGC-1α regulation in vitro and in vivo.
    Park MJ; Kim DI; Lim SK; Choi JH; Kim JC; Yoon KC; Lee JB; Lee JH; Han HJ; Choi IP; Kim HC; Park SH
    J Hepatol; 2014 Nov; 61(5):1151-7. PubMed ID: 25003952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone H3K9 Demethylase JMJD2B Plays a Role in LXRα-Dependent Lipogenesis.
    Kim JH; Jung DY; Kim HR; Jung MH
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New role of irisin in hepatocytes: The protective effect of hepatic steatosis in vitro.
    Park MJ; Kim DI; Choi JH; Heo YR; Park SH
    Cell Signal; 2015 Sep; 27(9):1831-9. PubMed ID: 25917316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LXR-α antagonist meso-dihydroguaiaretic acid attenuates high-fat diet-induced nonalcoholic fatty liver.
    Sim WC; Park S; Lee KY; Je YT; Yin HQ; Choi YJ; Sung SH; Park SJ; Park HJ; Shin KJ; Lee BH
    Biochem Pharmacol; 2014 Aug; 90(4):414-24. PubMed ID: 24955981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoic acid receptor-related orphan receptor α-induced activation of adenosine monophosphate-activated protein kinase results in attenuation of hepatic steatosis.
    Kim EJ; Yoon YS; Hong S; Son HY; Na TY; Lee MH; Kang HJ; Park J; Cho WJ; Kim SG; Koo SH; Park HG; Lee MO
    Hepatology; 2012 May; 55(5):1379-88. PubMed ID: 22183856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced expression of pro-inflammatory mediators and liver X-receptor-regulated lipogenic genes in non-alcoholic fatty liver disease and hepatitis C.
    Lima-Cabello E; García-Mediavilla MV; Miquilena-Colina ME; Vargas-Castrillón J; Lozano-Rodríguez T; Fernández-Bermejo M; Olcoz JL; González-Gallego J; García-Monzón C; Sánchez-Campos S
    Clin Sci (Lond); 2011 Mar; 120(6):239-50. PubMed ID: 20929443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of PRMT3 activity reduces hepatic steatosis without altering atherosclerosis susceptibility in apoE knockout mice.
    Hoekstra M; Nahon JE; de Jong LM; Kröner MJ; de Leeuw LR; Van Eck M
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1402-1409. PubMed ID: 30776415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor suppressor Menin acts as a corepressor of LXRα to inhibit hepatic lipogenesis.
    Cheng P; Li G; Yang SS; Liu R; Jin G; Zhou XY; Hu XG
    FEBS Lett; 2015 Oct; 589(20 Pt B):3079-84. PubMed ID: 25962847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reciprocal regulation of LXRα activity by ASXL1 and ASXL2 in lipogenesis.
    Park UH; Seong MR; Kim EJ; Hur W; Kim SW; Yoon SK; Um SJ
    Biochem Biophys Res Commun; 2014 Jan; 443(2):489-94. PubMed ID: 24321552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-1 and microRNA-206 suppress LXRα-induced lipogenesis in hepatocytes.
    Zhong D; Huang G; Zhang Y; Zeng Y; Xu Z; Zhao Y; He X; He F
    Cell Signal; 2013 Jun; 25(6):1429-37. PubMed ID: 23499676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orphan nuclear receptor DAX-1 acts as a novel corepressor of liver X receptor alpha and inhibits hepatic lipogenesis.
    Nedumaran B; Kim GS; Hong S; Yoon YS; Kim YH; Lee CH; Lee YC; Koo SH; Choi HS
    J Biol Chem; 2010 Mar; 285(12):9221-32. PubMed ID: 20080977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased MiR-155 Level in the Peripheral Blood of Non-Alcoholic Fatty Liver Disease Patients may Serve as a Biomarker and may Influence LXR Activity.
    Wang L; Zhang N; Wang Z; Ai DM; Cao ZY; Pan HP
    Cell Physiol Biochem; 2016; 39(6):2239-2248. PubMed ID: 27832630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
    Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
    J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nogo-B receptor deficiency increases liver X receptor alpha nuclear translocation and hepatic lipogenesis through an adenosine monophosphate-activated protein kinase alpha-dependent pathway.
    Hu W; Zhang W; Chen Y; Rana U; Teng RJ; Duan Y; Liu Z; Zhao B; Foeckler J; Weiler H; Kallinger RE; Thomas MJ; Zhang K; Han J; Miao QR
    Hepatology; 2016 Nov; 64(5):1559-1576. PubMed ID: 27480224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of adenosine monophosphate-activated protein kinase-p70 ribosomal S6 kinase-1 pathway in repression of liver X receptor-alpha-dependent lipogenic gene induction and hepatic steatosis by a novel class of dithiolethiones.
    Hwahng SH; Ki SH; Bae EJ; Kim HE; Kim SG
    Hepatology; 2009 Jun; 49(6):1913-25. PubMed ID: 19378344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transcription cofactor CRTC1 protects from aberrant hepatic lipid accumulation.
    Kim H
    Sci Rep; 2016 Nov; 6():37280. PubMed ID: 27869139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of microRNA-451 in non-alcoholic steatohepatitis inhibits fatty acid-induced proinflammatory cytokine production through the AMPK/AKT pathway.
    Hur W; Lee JH; Kim SW; Kim JH; Bae SH; Kim M; Hwang D; Kim YS; Park T; Um SJ; Song BJ; Yoon SK
    Int J Biochem Cell Biol; 2015 Jul; 64():265-76. PubMed ID: 25957914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of liver X receptor correlates with intrahepatic inflammation and fibrosis in patients with nonalcoholic fatty liver disease.
    Ahn SB; Jang K; Jun DW; Lee BH; Shin KJ
    Dig Dis Sci; 2014 Dec; 59(12):2975-82. PubMed ID: 25102981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver X receptor mediates hepatitis B virus X protein-induced lipogenesis in hepatitis B virus-associated hepatocellular carcinoma.
    Na TY; Shin YK; Roh KJ; Kang SA; Hong I; Oh SJ; Seong JK; Park CK; Choi YL; Lee MO
    Hepatology; 2009 Apr; 49(4):1122-31. PubMed ID: 19105208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.